Currently serves as a bioanalytics consultant for Lone Mountain Biotechnology
Previously Senior VP at Genentech (>20 years)
Co-founder and serves on the Board of Bioanalytics
SAB of StemCentryx, which sold to Abbvie for $5.8B
17 drugs approved in the US & EU
